Biological
Rubella Vaccine clinical trials
- studies test it
- 5
- open now
- 1
- in phase 3
- 1
- first study started
- 2015
Keep track of what changes. Save the Rubella Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
5 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 4
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (2) · PATH (1) · GlaxoSmithKline (1) · International Vaccine Institute (1)
Often tested with
Tested in the same studies.
Measles Vaccine (5) · Yellow Fever Vaccine (2) · R21 (1) · Vaccines, Combined (1) · Typhoid-Paratyphoid Vaccines (1) · Papillomavirus Vaccines (1)
Studies
Open first, then newest update. How each study uses Rubella Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 5
- Strengthening HPV Immunization Through EPI Leveraged DeliveryRecruitingPhase 2International Vaccine InstituteNCT07377656Written as Measles and rubella Vaccine
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingPhase 2PATHNCT06879327Written as Measles and Rubella Vaccine
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfantsCompletedPhase 2GlaxoSmithKlineNCT06213506Written as Measles and Rubella vaccine
- Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and RubellaCompletedPhase 2/3The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)NCT03148990Written as Measles and Rubella vaccine
- Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and RubellaCompletedPhase 1The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)NCT02196285Written as Double viral (MR) vaccine
Codes
What other systems call Rubella Vaccine · ClinicalTrials.gg INT035252
- MeSH (NLM) D012411Rubella VaccineOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012411 | Rubella Vaccine | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.